DONLAR BIOSYNTREX CORP

Donlar Biosyntrex Corp. has long been recognized in the Biological Products (No Diagnostic Substances) industry, serving research institutions, pharmaceutical firms, and biotech developers that rely on sterile biologics and specialty reagents for early-stage discovery and production support, and its operations align with SIC 2834 standards for manufacturers of non-diagnostic biologics; the company leverages specialized fermentation and purification technologies to supply high-quality proteins, antigens, and related compounds, while its governance emphasizes compliance with FDA and chemical safety regulations, resilience against raw material sourcing risks, intellectual property protection, and the need to maintain rigorous quality systems amid evolving clinical and environmental oversight; those closely monitoring the company can note the most recent disclosure was a Form 10-K filed in January 1999, and for current SEC filing activity, view live updates on Earnings Feed.

Source: Earnings Feed research · last updated 11/24/2025